In case you missed it: December 4 to December 9
A look back at this week's news.
Exploring Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis
Michael L. Krychman, MD, and Jack D. Sobel, MD, review the mechanisms of ibrexafungerp and how it might fit in the treatment spectrum for RVVC.
Impact of state mandatory IVF insurance coverage
State infertility insurance mandates are critical for improving access to infertility care. They also help to advance gender equality and reproductive rights.
IVF for women with previous recurrent ectopic pregnancy
Women with previous recurrent ectopic pregnancy (EP) have a significantly lower risk of EP following in vitro fertilization (IVF), compared to women with previous single EP, according to a retrospective cohort study published in the journal PLOS One.
Uterine anomalies in pregnancy
Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Leadership in the new reality
Although leadership in our post-pandemic climate is probably no more challenging than at any other time, it certainly feels that way.
Pre-Roe abortion services and trends in US
Investigators conducted a study to gather a baseline assessment of abortion incidence and service delivery prior to Roe v Wade being overturned earlier this year.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
